Perspectives in antisense therapeutics
- 1 October 1997
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 76 (1-3), 151-160
- https://doi.org/10.1016/s0163-7258(97)00108-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Antisense oligonucleotides: towards clinical trialsTrends in Biotechnology, 1996
- Modified oligonucleotides as therapeutic and diagnostic agentsCurrent Opinion in Biotechnology, 1995
- Novel enzymatic and immunological responses to oligonucleotidesToxicology Letters, 1995
- Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administrationBiochemical Pharmacology, 1995
- Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapyKidney International, 1995
- Detection of Ribonuclease H-Generated mRNA Fragments in Human Leukemia Cells Following Reversible Membrane Permeabilization in the Presence of Antisense OligodeoxynucleotidesAntisense Research and Development, 1995
- Pharmacokinetics of Antisense OligonucleotidesClinical Pharmacokinetics, 1995
- Study of antisense oligonucleotide phosphorothioates containing segments of oligodeoxynucleotides and 2′-o- methyloligoribonucleotidesBioorganic & Medicinal Chemistry Letters, 1994
- Complement Activation and Hemodynamic Changes Following Intravenous Administration of Phosphorothioate Oligonucleotides in the MonkeyAntisense Research and Development, 1994
- Specific regulation of gene expression by antisense, sense and antigene nucleic acidsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1990